W N M Hustinx

1.2k total citations
16 papers, 813 citations indexed

About

W N M Hustinx is a scholar working on Epidemiology, Immunology and Pharmacology. According to data from OpenAlex, W N M Hustinx has authored 16 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 5 papers in Immunology and 4 papers in Pharmacology. Recurrent topics in W N M Hustinx's work include Pneumonia and Respiratory Infections (6 papers), Immune Response and Inflammation (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). W N M Hustinx is often cited by papers focused on Pneumonia and Respiratory Infections (6 papers), Immune Response and Inflammation (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). W N M Hustinx collaborates with scholars based in Netherlands, Guinea-Bissau and Indonesia. W N M Hustinx's co-authors include Marc J. M. Bonten, Eelko Hak, Anne Marie G. A. de Smet, Tom Dormans, Mirelle Koeman, Ingeborg van der Tweel, Graham Ramsay, Andy M. Hoepelman, H.A. Verbrugh and André van der Ven and has published in prestigious journals such as The Lancet, American Journal of Respiratory and Critical Care Medicine and Antimicrobial Agents and Chemotherapy.

In The Last Decade

W N M Hustinx

16 papers receiving 774 citations

Peers

Countries citing papers authored by W N M Hustinx

Since Specialization

Citations

This map shows the geographic impact of W N M Hustinx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W N M Hustinx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W N M Hustinx more than expected).

Fields of papers citing papers by W N M Hustinx

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W N M Hustinx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W N M Hustinx. The network helps show where W N M Hustinx may publish in the future.

Co-authorship network of co-authors of W N M Hustinx

This figure shows the co-authorship network connecting the top 25 collaborators of W N M Hustinx. A scholar is included among the top collaborators of W N M Hustinx based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W N M Hustinx. W N M Hustinx is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Time for first antibiotic dose is not predictive for the early clinical failure of moderate–severe community-acquired pneumonia 2009 ·European Journal of Clinical Microbiology & Infectious Diseases ·Anke H. W. Bruns, Jan Jelrik Oosterheert, W N M Hustinx, Sandrine Gaillard, Eelko Hak, Andy I. M. Hoepelman	31
2	[Less ventilator-associated pneumonia after oral decontamination with chlorhexidine; a randomised trial]. 2008 ·PubMed ·Mirelle Koeman, (unknown), Eelko Hak, Jos Joore, H. A. H. Kaasjager, Anne Marie G. A. de Smet, Graham Ramsay, Tom Dormans, (unknown), (unknown), W N M Hustinx, Ingeborg van der Tweel, I. M. Hoepelman, M. J. M. Bonten	7
3	Oral Decontamination with Chlorhexidine Reduces the Incidence of Ventilator-associated Pneumonia 2006 ·American Journal of Respiratory and Critical Care Medicine ·Mirelle Koeman, André van der Ven, Eelko Hak, Hans C. A. Joore, Karin Kaasjager, Anne Marie G. A. de Smet, Graham Ramsay, Tom Dormans, Leon Aarts, (unknown), W N M Hustinx, Ingeborg van der Tweel, Andy M. Hoepelman, Marc J. M. Bonten	267
4	Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study 2006 ·BMJ ·Rachida el Moussaoui, Corianne A.J.M. de Borgie, Peterhans van den Broek, W N M Hustinx, Paul Bresser, Guido E.L. van den Berk, Jan‐Werner Poley, Bob van den Berg, Frans H. Krouwels, Marc J. M. Bonten, Carla Weenink, Patrick M. Bossuyt, Peter Speelman, Brent C. Opmeer, Jan M. Prins	232
5	Effects of granulocyte colony-stimulating factor (G-CSF) treatment on granulocyte function and receptor expression in patients with ventilator-dependent pneumonia 1998 ·Clinical & Experimental Immunology ·W N M Hustinx, Christoph Kessel, (unknown), (unknown), JW Lammers, I. M. Hoepelman	20
6	Evaluation of protection by two endotoxin-neutralizing IgM monoclonal antibodies in different peritonitis models 1997 ·Journal of Antimicrobial Chemotherapy ·W N M Hustinx, Barry Benaissa-Trouw, Theo Harmsen, Savannah Klein, J. Verhoef, Andy I. M. Hoepelman, (unknown)	1
7	Granulocyte colony‐stimulating factor enhances protection by anti‐K1 capsular IgM antibody in murine Escherichia coli sepsis 1997 ·European Journal of Clinical Investigation ·W N M Hustinx, Barry Benaissa-Trouw, (unknown), (unknown), (unknown), (unknown), J. Verhoef, Andy I. M. Hoepelman	5
8	Cross-protection by anti-core glycolipid antibodies: evidence from animal experiments 1997 ·Journal of Antimicrobial Chemotherapy ·W N M Hustinx, (unknown), Andy I. M. Hoepelman, J. Verhoef	8
9	A PHASE I SAFETY AND PHARMACOKINETIC STUDY OF A RECOMBINANT AMINO TERMINAL FRAGMENT OF BACTERICIDAL/ PERMEABILITY-INCREASING PROTEIN IN HEALTHY MALE VOLUNTEERS 1996 ·Shock ·Robert J. Bauer, Mark White, Nancy Wedel, Betty J Nelson, N. Friedmann, Albert Cohen, W N M Hustinx, Ada H. C. Kung	23
10	Effect of imipenem on monoclonal antibody-mediated protection against Escherichia coli O18K5 1996 ·Antimicrobial Agents and Chemotherapy ·(unknown), Barry Benaissa-Trouw, Luís Tavares, (unknown), W N M Hustinx, J. F. P. Schellekens, (unknown), J. Verhoef	1
11	Catherer-associated urinary tract infections: epidemiological, preventive and therapeutic considerations 1994 ·International Journal of Antimicrobial Agents ·W N M Hustinx, (unknown)	5
12	Aminoglycoside Dosage Regimens 1993 ·Clinical Pharmacokinetics ·W N M Hustinx, (unknown)	26
13	Systemic effects of inhalational methyl bromide poisoning: a study of nine cases occupationally exposed due to inadvertent spread during fumigation. 1993 ·Occupational and Environmental Medicine ·W N M Hustinx, (unknown), Alexander C. van Huffelen, J. Verwey, Jan Meulenbelt, T.J.F. Savelkoul	28
14	Prophylactic ciprofloxacin for catheter-associated urinary-tract infection 1992 ·The Lancet ·H.A. Verbrugh, (unknown), (unknown), (unknown), W N M Hustinx, (unknown), (unknown), Arie P.J. van Dijk	72
15	Delayed Antibiotic-Induced Lysis of Escherichia coli in vitro is Correlated with Enhancement of LPS Release 1992 ·Scandinavian Journal of Infectious Diseases ·(unknown), Albert J. de Neeling, (unknown), W N M Hustinx, Johan Wemer, Dick J. De Wildt	48
16	Impact of concurrent antimicrobial therapy on catheter-associated urinary tract infection 1991 ·Journal of Hospital Infection ·W N M Hustinx, A.J. Mintjes-de Groot, R P Verkooyen, H.A. Verbrugh	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact